Tarbox Family Office’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Tarbox Family Office’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-165	Closed	-$9K	–	1222
2020 Q3	$9K	Hold	165	–	–	﹤0.01%	407
2020 Q2	$5K	Hold	165	–	–	﹤0.01%	500
2020 Q1	$4K	Buy	165 +43	+35%	+$1.2K	﹤0.01%	500
2019 Q4	$2K	Buy	122 +35	+40%	+$560	﹤0.01%	904
2019 Q3	$1K	Buy	87 +20	+30%	+$241	﹤0.01%	1066
2019 Q2	$1K	Buy	+67	New	+$890	﹤0.01%	1068

Tarbox Family Office's MNTA Position: Q4 2020 in Review

Tarbox Family Office sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 165 shares — an estimated $9K sold.

Tarbox Family Office first reported a position in MNTA in Q2 2019 and held it in 6 quarters. The position peaked at $9K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Tarbox Family Office reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Tarbox Family Office sold 165 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $9K.
Tarbox Family Office first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2019 and held it in 6 quarters.
Tarbox Family Office's Momenta Pharmaceuticals, Inc. position peaked at $9K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Tarbox Family Office's 13F filing for Q4 2020, filed 27 Jan 2021.